Related Experiment Video
Updated: Jan 1, 2026

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
A Case Series: Adjunctive Treatment of Major Depressive Disorder in the Geriatric Population with the Methylphenidate
Kamal Patel1, Ashley Collins1, Suzanne Holroyd1
1Department of Psychiatry & Behavioral Medicine, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, USA.
Abstract:
Major depressive disorder can affect anyone regardless of age. In geriatric populations depression is often overlooked and untreated, which subsequently may lead to serious consequences. Almost one third of elderly patients with depression fail to respond to initial treatment and require adjunctive treatment. Methylphenidate is one such option, which is seldom used in the geriatric population to treat depression despite reports of improvement in symptoms of mood within a brief period of time. Methylphenidate is also available in a patch formulation that can be used in patient's nonadherent to the medication, which is reported to be an issue in as many as 75% of the geriatric population. Here we present three geriatric patients who were diagnosed with recurrent severe major depressive disorder without psychotic features. The three patients responded well with methylphenidate as adjunctive treatment to conventional antidepressants.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Drug Dosing: Geriatric Patients
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Pharmacodynamics in Geriatric Patients: Effects of Age
Alzheimer's Disease: Treatment
Drug Therapy
Antianxiety Medications

